SCHEMBL4368205

SCHEMBL4368205

CC(=O)OC[C@H]1OC(Oc2cc(C(=O)O)cc(OC3O[C@H](COC(C)=O)[C@@H](OC(C)=O)[C@H](OC(C)=O)[C@H]3OC(C)=O)c2O)[C@H](OC(C)=O)[C@@H](OC(C)=O)[C@@H]1OC(C)=O

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP2D6 P10635 1/20 0.52
▸ THRB P10828 1/20 0.52
▸ HSD17B10 Q99714 1/20 0.52
▸ TSHR P16473 1/20 0.51
▸ P4HB P07237 1/20 0.49
▸ PDIA4 P13667 1/20 0.49
▸ PDIA3 P30101 1/20 0.49
▸ LMNA P02545 2/20 0.47
▸ F11 P03951 1/20 0.47
▸ ELANE P08246 1/20 0.47
▸ CYP2C9 P11712 2/20 0.47
▸ MEN1 O00255 2/20 0.47
▸ CYP3A4 P08684 2/20 0.47
▸ KMT2A Q03164 2/20 0.47
▸ TP53 P04637 1/20 0.47
▸ USP2 O75604 2/20 0.47
▸ MAPK1 P28482 2/20 0.47
▸ TMPRSS2 O15393 1/20 0.47
▸ PDE5A O76074 1/20 0.47
▸ CA1 P00915 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4375052 1.00 CYP2D6 (0.52) CYP2D6THRBHSD17B10TSHRP4HB
SCHEMBL4369352 0.96 CA1 (0.53) CYP2D6THRBHSD17B10TSHRP4HB
SCHEMBL4379633 0.89 P4HB (0.48) CYP2D6THRBHSD17B10TSHRP4HB
SCHEMBL4367146 0.89 P4HB (0.48) CYP2D6THRBHSD17B10TSHRP4HB
SCHEMBL4368174 0.89 PTPN1 (0.51) CYP2D6THRBHSD17B10TSHRP4HB
SCHEMBL4362797 0.89 PTPN1 (0.51) CYP2D6THRBHSD17B10TSHRP4HB
SCHEMBL4371275 0.88 F11 (0.53) CYP2D6THRBHSD17B10TSHRP4HB
SCHEMBL4362777 0.88 F11 (0.53) CYP2D6THRBHSD17B10TSHRP4HB
SCHEMBL12651492 0.86 P4HB (0.47) CYP2D6THRBHSD17B10TSHRP4HB
SCHEMBL13587873 0.86 P4HB (0.47) CYP2D6THRBHSD17B10TSHRP4HB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7622563-B2 Process for producing glycoside MITSUI CHEMICALS, INC. (JP) 2009-11-24 — — US disclosed
US-20050272921-A1 Process for producing glycoside MITSUI CHEMICALS, INC. (JP) 2005-12-08 — — US disclosed
EP-1544207-A1 PROCESS FOR PRODUCING GLYCOSIDE Mitsui Chemicals, Inc. (JP) 2005-06-22 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050272921-A1 Process for producing glycoside HAAO, OGA, MGAM CYP2D6 1345/4885THRB 4271/4885HSD17B10 154/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback